Please assess the completion status of the following clinical trial:

Trial Title: Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects \> or equal to 18 years of age.~* Presence of candidemia (positive blood culture) or invasive candidiasis (histopathologic or cytopathologic examination of a needle aspiration or biopsy specimen from a normally sterile site excluding mucous membranes showing yeast cells) obtained within the prior 96 hours of the screening visit.~* Subjects who received no more than one prior dose of an echinocandin or polyene.~Exclusion Criteria:~* Subjects with hypersensitivity to anidulafungin, other echinocandins or azoles.~* Presence of confirmed or suspected Candida osteomyelitis, endocarditis or meningitis.~* Subjects with infected prosthetic devices which cannot be removed within 24 hours

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1. (Type: EXPERIMENTAL): Subjects receive anidulafungin IV followed by oral therapy with fluconazole or voriconazole.

Based on this trial design, predict the completion outcome and termination type (if applicable).